US2022145280A1PendingUtilityA1
Novel recombinant factor c and method for producing the same, and method for measuring endotoxin
Est. expiryDec 10, 2032(~6.4 yrs left)· nominal 20-yr term from priority
G01N 2333/96411G01N 33/56911C12N 9/6408G01N 33/579C12Y 304/21069C12Y 304/21084
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A horseshoe crab Factor C protein having activity of Factor C, wherein the horseshoe crab is selected from Tachypleus tridentatus, Limulus polyphemus, and Carcinoscorpius rotundicauda, and wherein the horseshoe crab Factor C protein is produced through being recombinantly expressed from a Chinese Hamster Ovary (CHO) DG44 cell or HEK cell.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A horseshoe crab Factor C protein having activity of Factor C,
wherein the horseshoe crab is selected from the group consisting of Tachypleus tridentatus, and Limulus polyphemus, wherein the Factor C protein is produced through being recombinantly expressed from a Chinese Hamster Ovary cell, secreted into a culture supernatant and recovered from the culture supernatant, and wherein the Factor C protein contains (α-2,3)-linked terminal sialic acid in a greater amount, as compared with a corresponding Factor C protein recombinantly expressed using Sf9 as a host cell.
2 . The horseshoe crab Factor C protein according to claim 1 , which has a molecular weight of 115 kDa to 130 kDa, as measured through SDS-PAGE under a non-reducing condition.
3 . An endotoxin assay kit comprising the Factor C protein according to claim 1 and one or more elements.
4 . A method for measuring endotoxin in a test specimen using an endotoxin assay agent comprising the Factor C protein according to claim 1 .Join the waitlist — get patent alerts
Track US2022145280A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.